Medical nutrition therapy is the essential cornerstone for effective treatment of "refractory" severe hypertriglyceridemia regardless of pharmaceutical treatment: Evidence from a Lipid Management Program

Journal of Clinical Lipidology

Volumn 9, Issue 4, 2015, Pages 559-567

  Rhodes, Katherine S ^a   Weintraub, Martha ^a   Marchlewicz, Elizabeth H ^b   Rubenfire, Melvyn ^a   Brook, Robert D ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cardiovascular; Medical nutrition therapy; Pancreatitis; Severe hypertriglyceridemia; Triglycerides

Indexed keywords

ANTILIPEMIC AGENT; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; APOLIPOPROTEIN E; BILE ACID SEQUESTRANT; C REACTIVE PROTEIN; CREATININE; FIBRIC ACID DERIVATIVE; FISH OIL; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; HOMOCYSTEINE; INSULIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN; NICOTINIC ACID DERIVATIVE; THYROTROPIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BODY MASS; CHOLESTEROL BLOOD LEVEL; DIET THERAPY; DIETARY COMPLIANCE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HIGH FIBER DIET; HUMAN; HYPERTRIGLYCERIDEMIA; LOW CARBOHYDRATE DIET; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; MEDICAL NUTRITION THERAPY; NUTRITIONAL ASSESSMENT; NUTRITIONAL COUNSELING; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PATIENT COUNSELING; PHARMACEUTICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; THERAPY EFFECT; WEIGHT REDUCTION; AGED; BLOOD; CARDIOVASCULAR DISEASES; MIDDLE AGED; PANCREATITIS; PATHOLOGY; RISK FACTOR; TREATMENT OUTCOME;

ADULT; AGED; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; FEMALE; FIBRIC ACIDS; HUMANS; HYPERTRIGLYCERIDEMIA; HYPOLIPIDEMIC AGENTS; MALE; MIDDLE AGED; NUTRITION THERAPY; PANCREATITIS; RISK FACTORS; TREATMENT OUTCOME; TRIGLYCERIDES;

EID: 84938206373     PISSN: 19332874     EISSN: 18764789     Source Type: Journal    
DOI: 10.1016/j.jacl.2015.03.012     Document Type: Article

References (30)

1. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report Circulation 106 2002 3143 3421
2. K.C. Maki, H.E. Bays, and M.R. Dicklin Treatment options for the management of hypertriglyceridemia: strategies based on the best available evidence J Clin Lipidol 6 2012 413 426
3. L. Berglund, J.D. Brunzell, A.C. Goldberg, and et al. Evaluation and treatment of hypertriglyceridemia: an Endocrine Society clinical practice guideline J Clin Endocrinol Metab 97 9 2012 2969 2989
4. M.J. Chapman, H.N. Ginsberg, P. Amarenco, et al. for the European Atherosclerosis Society Consensus Panel Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management Eur Heart J 32 2011 1345 1361
5. M. Miller, N.J. Stone, C. Ballantyne, et al. American Heart Association Clinical Lipidology, Thrombosis, and Prevention Committee of the Council on Nutrition, Physical Activity, and Metabolism; Council on Atherosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Nursing; Council on the Kidney in Cardiovascular Disease Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association Circulation 123 2011 2292 2333
6. V.R. Polansi, V. Nambi, S.S. Virani, and et al. Efficacy and tolerability of multidrug therapy for hypertriglyceridemia J Clin Lipidol 3 2009 341 344
7. D. Yadav, and C.S. Pitchumoni Issues in hyperlipidemic pancreatitis J Clin Gastroenterol 36 2003 54 62
8. E.S. Ford, C. Li, G. Zhao, W.S. Pearson, and A.H. Mokdad Hypertriglyceridemia and its pharmacologic treatment among US adults Arch Intern Med 169 2009 572 578
9. C. Lloret Linares, A.L. Pelletier, S. Czernichow, and et al. Acute pancreatitis in a cohort of 129 patients referred for severe hypertriglyceridemia Pancreas 37 2008 13 18
10. W.H. Capell, and R.H. Eckel Severe hypertriglyceridemia with a history of treatment failure Nat Clin Pract Endocrinol Metab 1 1 2005 53 58
11. R.C. Oh, and J.B. Lanier Management of hypertriglyceridemia Am Fam Physician 75 9 2007 1365 1371
12. S. Sandhu, A. Al-Sarraf, C. Taraboanta, J. Frohlich, and G.A. Francis Incidence of pancreatitis, secondary causes, and treatment of patients referred to a specialty lipid clinic with severe hypertriglyceridemia: a retrospective cohort study Lipids Health Dis 10 2011 157
13. V.G. Athyros, O.I. Giouleme, N.L. Nikolaidis, and et al. Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis J Clin Gastroenterol 34 4 2002 472 475
14. Disorders of Lipid Metabolism. Evidenced-based Nutrition Practice Guideline. Academy of Nutrition and Dietetics. Available at: http://www.adaevidencelibrary.com/topic.cfm?cat=4527&auth=. Accessed December 16, 2014.
15. Exchange lists for meal planning 1995 American Diabetes Association and the American Dietetic Association Alexandria, Va, and Chicago, Ill
16. M. Okada, H. Matsui, Y. Ito, A. Fujiwara, and K. Inano Low-density lipoprotein cholesterol can be chemically measured: a new superior method J Lab Clin Med 132 1998 195 201
17. T.A. Jacobson, M.K. Ito, K.C. Maki, and et al. National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1: executive summary J Clin Lipidol 8 5 2014 473 488
18. B. Jacobs, G. De Angelis-Schierbaum, S. Egert, G. Assmann, and M. Kratz Individual serum triglyceride responses to high-fat and low-fat diets differ in men with modest and severe hypertriglyceridemia J Nutr 134 2004 1400 1405
19. P.M. Kris-Etherton, D.S. Taylor, and G. Zhao Is there an optimal diet for the hypertriglyceridemic patient? J Cardiovasc Risk 7 5 2000 333 337
20. R. Do, C.J. Willer, E.M. Schmidt, and et al. Common variants associated with plasma triglycerides and risk for coronary artery disease Nat Genet 45 11 2013 1345 1352
21. Global Lipids Genetics Consortium Discovery and refinement of loci associated with lipid levels Nat Genet 45 11 2013 1274 1285
22. W.H. Capell, K.P. Spiegelman, and R.H. Eckel Therapeutic targets in severe hypertriglyceridemia Drug Disc Today: Dis Mech 1 2 2004 171 177
23. M. Stahre, T. Naimi, R. Brewer, and J. Holt Measuring average alcohol consumption: the impact of including binge drinks in quantity-frequency calculations Addiction 101 2006 1711 1718
24. B. Klop, A.T. doRego, and M.C. Cabezas Alcohol and plasma triglycerides Curr Opin Lipidol 24 4 2014 321 326
25. F.A. Lederle, and H.E. Bloomfield Drug treatment of asymptomatic hypertriglyceridemia to prevent pancreatitis: where is the evidence? Ann Intern Med 157 9 2012 662 664
26. D. Preiss, M.J. Tikkanen, P. Welsh, and et al. Lipid-modifying therapies and risk of pancreatitis: a meta-analysis JAMA 308 8 2012 804 811
27. G.A. Nicholas, B. Arondekar, and T.A. Jacobson Hospital use and medical care costs up to 5 years after triglyceride lowering among people with severe hypertriglyceridemia J Clin Lipidol 6 2012 443 449
28. J.B. Christian, B. Arondekar, E.K. Buysman, S.L. Johnson, J.D. Seeger, and T.A. Jacobson Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia J Clin Lipidol 6 2012 450 461
29. J.B. Christian, B. Arondekar, E.K. Buysman, T.A. Johnson, R.G. Snipes, and R.I. Horwitz Determining triglyceride reduction needed for clinical impact in severe hypertriglyceridemia Am J Med 127 2014 36 44
30. A. Hauenschild, N. Ewald, H. Schnell-Kretschmer, M. Porsch-Oezcueruemez, H.U. Kloer, and P.H. Hardt Successful long-term treatment of severe hypertriglyceridemia by feedback control with lipid self-monitoring Ann Nutr Metab 52 2008 215 220